Michael did provide an update, of sorts, on the quarterly investor call recently.
The Prilocaine and Lidocaine market is underserved currently due to supply shortages. He elaborated by saying that all supply is sold out as soon as available. Padagis may have 100% of the market in one time period as no competitors have stock and vice versa. In that way the market share statistics aren’t very reliable. But they are selling everything they can produce.
Ann: Launch of Dapsone 5%, Gel in the United States, page-32
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
